Epic Research

Tuesday, February 5, 2013

Epic Update : Sun Pharmaceuticals Industries

Sun Pharmaceuticals Industries’ subsidiary has received US Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for generic version of Doxil, Doxorubicin HCI Liposome Injection USP 2mg/ml, packaged in 20mg/10ml and 50mg/25ml single use vials.

Get Free MCX TipsStock TipsForex Tips & NCDEX Tips,Commodity TipsShare Tipscommodity tips free trialnifty free tipscommodity trading tipsshares tipsShare Market TipsStock Market Tipsfree stock tips on mobileStock trading tipsIntraday Tips.

No comments:

Post a Comment